Dr. Ingrid Elise Van Swearingen, MD

Dr. Van Swearingen practices at UW Medical Center - Montlake in Seattle, Washington, part of University of Washington.

Dr. Van Swearingen's NPI, 1104265735, was assigned on June 17, 2013. Dr. Van Swearingen graduated from University of Washington School of Medicine in 2013. Dr. Van Swearingen holds Washington license MD60781095.

Dr. Van Swearingen's primary practice is UW Medical Center - Montlake, at 1959 NE Pacific St Box 356151, Seattle, WA 98195 in King County. The practice phone is (206) 598-3300.

Dr. Van Swearingen's primary practice is UW Medical Center - Montlake in Seattle, Washington, part of University of Washington. Dr. Van Swearingen is also affiliated with Harborview Medical Center. The medical group on file is UW Physicians. Dmand AI also links Dr. Van Swearingen to 1 more hospital, 1 group practice or clinic, 1 home health agency, 1 hospital outpatient department and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Van Swearingen practices, 6 sites in all. Vendor and product names are available with a free account.

Family medicine is Dr. Van Swearingen's primary specialty in the NPI Registry, under taxonomy code 207Q00000X. Dr. Van Swearingen is board certified in family medicine by the American Board of Family Medicine. Dr. Van Swearingen is licensed in Washington.

CMS data shows 803 Medicare services from Dr. Van Swearingen across 11 procedure codes in 2024, for 208 Medicare patients. Medicare paid $49,039 for them. Every service was in an office.

CMS counts 208 Medicare patients who saw Dr. Van Swearingen in 2024. The largest group is 65 to 74, with 84 patients. 70% of them have high blood pressure, and 65% have high cholesterol. 6% are also on Medicaid. Their average risk score is 1.15, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Van Swearingen's median patient age at 59, with 60% women.

In 2024, Dr. Van Swearingen wrote 4,408 Medicare Part D claims for 363 patients. 90% of them were for generic drugs. CMS names the drug for 3,781 of them, across 90 drugs with 11 or more claims each, at $229,709 in total drug cost. In 2023, CMS named 3,810 claims across 90 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 94 out of 100 for Dr. Van Swearingen for performance year 2024, reported through an alternative payment model (APM). Dr. Van Swearingen accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Van Swearingen as offering telehealth.

Skin biopsy: 1 to 10 procedures (CMS shows small counts as a range)

CMS Open Payments shows 2 general payments to Dr. Van Swearingen from 1 drug or device company in 2019. Food and beverage make up the largest share, 100% of the total. Boehringer Ingelheim Pharmaceuticals, Inc. paid the most, $56.

Dr. Van Swearingen graduated from University of Washington School of Medicine in 2013.